BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10732782)

  • 1. Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas.
    Taylor ST; Hickman JA; Dive C
    Endocr Relat Cancer; 1999 Mar; 6(1):21-3. PubMed ID: 10732782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Taylor ST; Hickman JA; Dive C
    J Natl Cancer Inst; 2000 Jan; 92(1):18-23. PubMed ID: 10620629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.
    Ghia P; Boussiotis VA; Schultze JL; Cardoso AA; Dorfman DM; Gribben JG; Freedman AS; Nadler LM
    Blood; 1998 Jan; 91(1):244-51. PubMed ID: 9414291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms.
    Ghia P; Caligaris-Cappio F
    Adv Cancer Res; 2000; 79():157-73. PubMed ID: 10818680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS; Boise LH; Gottschalk AR; Quintans J; Thompson CB; Klaus GG
    Eur J Immunol; 1995 May; 25(5):1352-7. PubMed ID: 7539757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax.
    de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A
    Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-ligation of alpha4beta1 integrin and TCR rescues human thymocytes from steroid-induced apoptosis.
    Zaitseva MB; Mojcik CF; Salomon DR; Shevach EM; Golding H
    Int Immunol; 1998 Oct; 10(10):1551-61. PubMed ID: 9796922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.
    Szocinski JL; Khaled AR; Hixon J; Halverson D; Funakoshi S; Fanslow WC; Boyd A; Taub DD; Durum SK; Siegall CB; Longo DL; Murphy WJ
    Blood; 2002 Jul; 100(1):217-23. PubMed ID: 12070030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLA-4-dependent adhesion in follicular non-Hodgkin's lymphomas.
    Ishii G; Harigaya K; Soeta S; Mikata A
    Hematol Pathol; 1995; 9(3-4):155-69. PubMed ID: 8655460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
    de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
    J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of endogenous bcl-2 and bcl-xL in thymic lymphomas do not diminish their sensitivity to etoposide-induced apoptosis.
    Matuszyk J; Kalas W; Cebrat M; Strzadala L
    Anticancer Res; 2001; 21(4A):2677-80. PubMed ID: 11724338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.
    Travert M; Ame-Thomas P; Pangault C; Morizot A; Micheau O; Semana G; Lamy T; Fest T; Tarte K; Guillaudeux T
    J Immunol; 2008 Jul; 181(2):1001-11. PubMed ID: 18606651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 inhibits B cell apoptosis by upregulating bcl-xL expression and blocking oxidant accumulation.
    Fang W; Nath KA; Mackey MF; Noelle RJ; Mueller DL; Behrens TW
    Am J Physiol; 1997 Mar; 272(3 Pt 1):C950-6. PubMed ID: 9124531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
    Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
    Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis.
    Koopman G; Keehnen RM; Lindhout E; Zhou DF; de Groot C; Pals ST
    Eur J Immunol; 1997 Jan; 27(1):1-7. PubMed ID: 9021991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.